162 related articles for article (PubMed ID: 26973066)
1. Effect of different detoxification procedures on the residual pertussis toxin activities in vaccines.
Yuen CT; Asokanathan C; Cook S; Lin N; Xing D
Vaccine; 2016 Apr; 34(18):2129-34. PubMed ID: 26973066
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the carbohydrate binding and ADP-ribosyltransferase activities of chemically detoxified pertussis toxins.
Oh H; Kim BG; Nam KT; Hong SH; Ahn DH; Choi GS; Kim H; Hong JT; Ahn BY
Vaccine; 2013 Jun; 31(29):2988-93. PubMed ID: 23664992
[TBL] [Abstract][Full Text] [Related]
3. ADP-ribosylation activity in pertussis vaccines and its relationship to the in vivo histamine-sensitisation test.
Gomez SR; Yuen CT; Asokanathan C; Douglas-Bardsley A; Corbel MJ; Coote JG; Parton R; Xing DK
Vaccine; 2007 Apr; 25(17):3311-8. PubMed ID: 17287049
[TBL] [Abstract][Full Text] [Related]
4. Development of a carbohydrate binding assay for the B-oligomer of pertussis toxin and toxoid.
Gomez SR; Xing DK; Corbel MJ; Coote J; Parton R; Yuen CT
Anal Biochem; 2006 Sep; 356(2):244-53. PubMed ID: 16782039
[TBL] [Abstract][Full Text] [Related]
5. Genetically detoxified pertussis toxin (PT-9K/129G): implications for immunization and vaccines.
Seubert A; D'Oro U; Scarselli M; Pizza M
Expert Rev Vaccines; 2014 Oct; 13(10):1191-204. PubMed ID: 25183193
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular Immunization.
Acquaye-Seedah E; Reczek EE; Russell HH; DiVenere AM; Sandman SO; Collins JH; Stein CA; Whitehead TA; Maynard JA
Infect Immun; 2018 Jun; 86(6):. PubMed ID: 29581192
[TBL] [Abstract][Full Text] [Related]
7. Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines.
Markey K; Asokanathan C; Feavers I
Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31319496
[TBL] [Abstract][Full Text] [Related]
8. An ELISA method to estimate the mono ADP-ribosyltransferase activities: e.g in pertussis toxin and vaccines.
Asokanathan C; Tierney S; Ball CR; Buckle G; Day A; Tanley S; Bristow A; Markey K; Xing D; Yuen CT
Anal Biochem; 2018 Jan; 540-541():15-19. PubMed ID: 29108883
[TBL] [Abstract][Full Text] [Related]
9. Unbinding forces of single pertussis toxin-antibody complexes measured by atomic force spectroscopy correlate with their dissociation rates determined by surface plasmon resonance.
Moreno N; Chevalier M; Ronzon F; Manin C; Dupuy M; Krell T; Rieu JP
J Mol Recognit; 2011; 24(6):1105-14. PubMed ID: 22038817
[TBL] [Abstract][Full Text] [Related]
10. Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen.
Kimura A; Mountzouros KT; Schad PA; Cieplak W; Cowell JL
Infect Immun; 1990 Oct; 58(10):3337-47. PubMed ID: 2119344
[TBL] [Abstract][Full Text] [Related]
11. Role of pertussigen (pertussis toxin) on the mouse protective activity of vaccines made from Bordetella species.
Munoz JJ; Peacock MG
Microbiol Immunol; 1989; 33(4):341-55. PubMed ID: 2549344
[TBL] [Abstract][Full Text] [Related]
12. Investigating pertussis toxin and its impact on vaccination.
Coutte L; Locht C
Future Microbiol; 2015; 10(2):241-54. PubMed ID: 25689536
[TBL] [Abstract][Full Text] [Related]
13. The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies.
Ibsen PH
Vaccine; 1996 Apr; 14(5):359-68. PubMed ID: 8735545
[TBL] [Abstract][Full Text] [Related]
14. Antibodies recognizing protective pertussis toxin epitopes are preferentially elicited by natural infection versus acellular immunization.
Sutherland JN; Chang C; Yoder SM; Rock MT; Maynard JA
Clin Vaccine Immunol; 2011 Jun; 18(6):954-62. PubMed ID: 21508166
[TBL] [Abstract][Full Text] [Related]
15. Reporter cell lines for detection of pertussis toxin in acellular pertussis vaccines as a functional animal-free alternative to the in vivo histamine sensitization test.
Hoonakker ME; Verhagen LM; van der Maas L; Sloots A; Hendriksen CFM
Vaccine; 2017 Feb; 35(8):1152-1160. PubMed ID: 28129894
[TBL] [Abstract][Full Text] [Related]
16. Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicity.
Ausar SF; Zhu S; Duprez J; Cohen M; Bertrand T; Steier V; Wilson DJ; Li S; Sheung A; Brookes RH; Pedyczak A; Rak A; Andrew James D
Commun Biol; 2020 Aug; 3(1):427. PubMed ID: 32759959
[TBL] [Abstract][Full Text] [Related]
17. Relationship between structure and biological and protective activities of pertussis toxin.
Sato H; Sato Y
Dev Biol Stand; 1991; 73():121-32. PubMed ID: 1723387
[TBL] [Abstract][Full Text] [Related]
18. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
Cyr T; Menzies AJ; Calver J; Whitehouse LW
Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
[TBL] [Abstract][Full Text] [Related]
19. Identification of peptides that mimic the pertussis toxin binding site on bovine fetuin.
Bogdan JA; Yuan W; Long-Rowe KO; Sarwar J; Brucker EA; Blake MS
Appl Environ Microbiol; 2003 Oct; 69(10):6272-9. PubMed ID: 14532091
[TBL] [Abstract][Full Text] [Related]
20. Detection of residual pertussis toxin in vaccines using a modified ribosylation assay.
Yuen CT; Canthaboo C; Menzies JA; Cyr T; Whitehouse LW; Jones C; Corbel MJ; Xing D
Vaccine; 2002 Nov; 21(1-2):44-52. PubMed ID: 12443661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
